Becton Dickinson & Co (BDX)
224.00
-1.45
(-0.64%)
USD |
NYSE |
Nov 22, 16:00
224.04
+0.04
(+0.02%)
Pre-Market: 20:00
Becton Dickinson Enterprise Value: 82.69B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 82.69B |
| November 21, 2024 | 83.11B |
| November 20, 2024 | 82.23B |
| November 19, 2024 | 82.30B |
| November 18, 2024 | 82.72B |
| November 15, 2024 | 83.03B |
| November 14, 2024 | 83.61B |
| November 13, 2024 | 84.78B |
| November 12, 2024 | 84.79B |
| November 11, 2024 | 85.76B |
| November 08, 2024 | 84.90B |
| November 07, 2024 | 83.59B |
| November 06, 2024 | 87.34B |
| November 05, 2024 | 86.54B |
| November 04, 2024 | 85.68B |
| November 01, 2024 | 85.94B |
| October 31, 2024 | 85.47B |
| October 30, 2024 | 86.34B |
| October 29, 2024 | 86.60B |
| October 28, 2024 | 87.00B |
| October 25, 2024 | 86.78B |
| October 24, 2024 | 86.92B |
| October 23, 2024 | 87.47B |
| October 22, 2024 | 87.23B |
| October 21, 2024 | 87.47B |
| Date | Value |
|---|---|
| October 18, 2024 | 88.40B |
| October 17, 2024 | 87.41B |
| October 16, 2024 | 87.39B |
| October 15, 2024 | 87.84B |
| October 14, 2024 | 87.32B |
| October 11, 2024 | 86.31B |
| October 10, 2024 | 86.03B |
| October 09, 2024 | 86.80B |
| October 08, 2024 | 86.50B |
| October 07, 2024 | 86.58B |
| October 04, 2024 | 86.80B |
| October 03, 2024 | 86.56B |
| October 02, 2024 | 87.25B |
| October 01, 2024 | 87.80B |
| September 30, 2024 | 87.64B |
| September 27, 2024 | 83.82B |
| September 26, 2024 | 82.59B |
| September 25, 2024 | 82.00B |
| September 24, 2024 | 82.50B |
| September 23, 2024 | 81.86B |
| September 20, 2024 | 81.50B |
| September 19, 2024 | 81.83B |
| September 18, 2024 | 80.95B |
| September 17, 2024 | 80.86B |
| September 16, 2024 | 81.66B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
71.87B
Minimum
Mar 23 2020
98.12B
Maximum
Jul 27 2023
85.67B
Average
85.11B
Median
Jul 07 2021
Enterprise Value Benchmarks
| Boston Scientific Corp | 141.27B |
| Abbott Laboratories | 211.67B |
| Baxter International Inc | 28.54B |
| Merit Medical Systems Inc | 6.366B |
| ResMed Inc | 36.04B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 421.00M |
| Revenue (Quarterly) | 5.437B |
| Total Expenses (Quarterly) | 4.617B |
| EPS Diluted (Quarterly) | 1.45 |
| Gross Profit Margin (Quarterly) | 46.26% |
| Profit Margin (Quarterly) | 7.74% |
| Earnings Yield | 2.65% |
| Operating Earnings Yield | 4.43% |
| Normalized Earnings Yield | 3.244 |